BioCentury
ARTICLE | Clinical News

Abraxane paclitaxel regulatory update

June 20, 2005 7:00 AM UTC

The partners submitted a marketing application to Health Canada for Abraxane to treat metastatic breast cancer. The solvent-free nanoparticle albumin-bound formulation of paclitaxel was approved in th...